耐万古霉素肠球菌感染防治专家共识（Expert consensus on prevention and treatment of vancomycin resistant enterococci）.docVIP

耐万古霉素肠球菌感染防治专家共识（Expert consensus on prevention and treatment of vancomycin resistant enterococci） Expert consensus on prevention and treatment of vancomycin resistant enterococci Committee of experts on the prevention and treatment of vancomycin resistant enterococci Enterococci are widely distributed in nature, often living in the intestines of people, animals and the female urogenital system, and are human beings One of the normal flora of the class. In recent years, due to the widespread use of antibacterial drugs, it has originally been on beta lactam Aminoglycoside antibiotics, which are resistant to enterococci, are further expanded and gradually formed Multidrug-resistant bacteria. Vancomycin resistant enterococci (vancomycin, resistant, enterococc) are present in China VRE) the incidence of infection is increasing year by year, and VRE has become an important pathogen of nosocomial infection The emergence of a [1, 2], poses new challenges to clinical microbiology and epidemiology. In order to further standardize And optimize the prevention and treatment of VRE infected patients, Journal of Chinese clinical and infectious diseases (electronic version) Edited by the editorial department of the medical reference and infectious diseases channel and organized some experts in China, we have combined many years of experience The collation and analysis of relevant data forms an expert consensus on the prevention and treatment of vancomycin resistant enterococci Abbreviation consensus. The level of evidence based evidence for this consensus is shown in table 1. Table 1 level of evidence based evidence for recommended programmes Level of evidence data type Class I evidence was obtained in at least one well-designed randomized controlled clinical trial Class II -1 level evidence was well designed to obtain evidence in a non randomized controlled trial II. Class -2 evidence design evidence for good cohort studies or case control studies (preferably multicenter studies)